Expertise in
4
conditions

Jurgen Geisler

NO 
Expertise in
4
conditions
NO 

Overview

Jurgen Geisler practices practicing medicine in Norway.

Mr. Geisler is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Melanoma, Triple-Negative Breast Cancer, and Cytomegalovirus Infection.

He is actively involved in clinical research, co-authoring 90 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Norway
Other Locations
Oslo, Norway
Bergen, 5021, Norway

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial
PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Radiation, Drug, Procedure
Study Drugs: Neoadjuvant Tamoxifen+Goserelin, Neoadjuvant Letrozole, Neoadjuvant Docetaxel+Cyclophosphamide, Neoadjuvant Docetaxel, Neoadjuvant Docetaxel+Trastuzumab+Pertuzumab, Neoadjuvant, Neoadjuvant Olaparib, Neoadjuvant Cyclophosphamide, Adjuvant Trastuzumab, Adjuvant Letrozole, Adjuvant Tamoxifen+Goserelin, Adjuvant Palbociclib, Adjuvant Epirubicin+Cyclophosphamide
Study Phase: Phase 2
Presurgical Treatment With Ribociclib and Letrozole in Patients With Locally Advanced Breast Cancer: the NEOLETRIB Study.
Presurgical Treatment With Ribociclib and Letrozole in Patients With Locally Advanced Breast Cancer: the NEOLETRIB Study.
Enrollment Status: Completed
Publish Date: August 02, 2024
Intervention Type: Drug
Study Drugs: Letrozole, Ribociclib, Goserelin
Study Phase: Phase 2
Treatment of Patients With Advanced Breast Cancer Harboring TP53 Mutations With Dose-dense Cyclophosphamide - the p53 Breast Cancer Trial
Treatment of Patients With Advanced Breast Cancer Harboring TP53 Mutations With Dose-dense Cyclophosphamide - the p53 Breast Cancer Trial
Enrollment Status: Active_not_recruiting
Publish Date: January 12, 2024
Intervention Type: Drug
Study Drug: Cyclophosphamide
Study Phase: Phase 2
View 2 Less Clinical Trials

90 Total Publications

Immune cell landscape and metabolic gene activity distinguish triple negative from luminal A-like ductal carcinoma in situ.
Immune cell landscape and metabolic gene activity distinguish triple negative from luminal A-like ductal carcinoma in situ.
Journal: Scientific reports
Published: March 20, 2026

Frequently Asked Questions about Jurgen Geisler

Is Jurgen Geisler a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Jurgen Geisler is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jurgen Geisler participate in research or clinical trials?

Yes. Jurgen Geisler has published 90 articles and abstracts on conditions like Breast Cancer. You can view a list of Jurgen Geisler's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Geisler's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile